Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
early access program
Description:
An early access program provides eligible patients access to medicines before they are widely marketed or formally available through routine care.
Related topics:
Pharmaceutical Economics and Policy (11%),
Prostate Cancer Treatment and Research (10%)
OpenAlex ID:
keywords/early-access-program
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
2013
·
Christophe Hézode
, Hélène Fontaine
, et al.
·
Journal of Hepatology
·
456
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
2016
·
Fred Saad
, Joan Carles
, et al.
·
The Lancet Oncology
·
303
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
2022
·
Nicolas Girard
, Jair Bar
, et al.
·
Journal of Thoracic Oncology
·
276
PDF
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
2024
·
Paula Rodriguez-Otero
, Saad Usmani
, et al.
·
The Lancet Oncology
·
199
Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study
2019
·
Anne Quinquenel
, Luc-Matthieu Fornecker
, et al.
·
Blood
·
148
PDF
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort
2020
·
Clairelyne Dupin
, Drifa Belhadi
, et al.
·
Clinical & Experimental Allergy
·
143
Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program
2024
·
Maximilian Wiesenfarth
, Johannes Dorst
, et al.
·
EClinicalMedicine
·
129
PDF
8 Safety of Telaprevir or Boceprevir in Combination With Peginterferon Alfa/ribavirin, in Cirrhotic Non Responders. First Results of the French Early Access Program (anrs Co20-cupic)
2012
·
C. Hezode
, C. Dorival
, et al.
·
Journal of Hepatology
·
92
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome
2021
·
J. Helen Cross
, Bradley S. Galer
, et al.
·
Seizure
·
89
PDF
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
2017
·
Christophe Hézode
, Pascal Lebray
, et al.
·
Liver International
·
85
PDF
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
2020
·
Camille Taillé
, Pascal Chanez
, et al.
·
European Respiratory Journal
·
83
PDF
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R
2024
·
A.R. Filippi
, J. Bar
, et al.
·
ESMO Open
·
76
PDF
An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC
2020
·
Viola W. Zhu
, Yen-Ting Lin
, et al.
·
Journal of Thoracic Oncology
·
73
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
2021
·
Candice Hober
, Lisa Fredeau
, et al.
·
Cancers
·
67
PDF
Early access programs: Benefits, challenges, and key considerations for successful implementation
2016
·
Sanjaykumar Patil
·
Perspectives in Clinical Research
·
67
Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program
2020
·
Laurence Albiges
, Aude Fléchon
, et al.
·
European Journal of Cancer
·
62
PDF
Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme
2022
·
Ludovic Samalin
, Maud Rothärmel
, et al.
·
International Journal of Psychiatry in Clinical Practice
·
61
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
2019
·
Axel Heidenreich
, Silke Gillessen
, et al.
·
BMC Cancer
·
57
PDF
Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions.
2021
·
Alison M. Schram
, Eileen Mary O'Reilly
, et al.
·
Journal of Clinical Oncology
·
56
Real-world Cabazitaxel Safety: The Italian Early-Access Program in Metastatic Castration-Resistant Prostate Cancer
2013
·
Sergio Bracarda
, Angela Gernone
, et al.
·
Future Oncology
·
53
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program
2021
·
Nikolaj Frost
, Petros Christopoulos
, et al.
·
Therapeutic Advances in Medical Oncology
·
52
PDF
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
2019
·
Cristina Scavone
, Gabriella di Mauro
, et al.
·
Frontiers in Pharmacology
·
50
PDF
An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
2022
·
Renzo Guerrini
, Nicola Specchio
, et al.
·
Epilepsia Open
·
47
PDF
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
2013
·
M Colombo
, I Fernández
, et al.
·
Gut
·
47
PDF
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
2020
·
Evangelos Terpos
, Karthik Ramasamy
, et al.
·
Annals of Hematology
·
44
Show more works
View as search
Works count:
713
Citation count:
5,757
Year
Topic
Type